ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Viral Vector Production (Research-use) Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-4C11915
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Viral Vector Production Research use Market Research Report 2022
BUY CHAPTERS

Global Viral Vector Production (Research-use) Market Research Report 2025

Code: QYRE-Auto-4C11915
Report
June 2025
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck KGaA
Lonza
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Thermo Fisher Scientific
Waisman Biomanufacturing
Yposkesi
Novasep Holding S.A.S.
Vigene Biosciences, Inc.
GENERAL ELECTRIC COMPANY (GE Healthcare)
Cevec Pharmaceuticals GmbH
Wuxi Apptec Co.,Ltd.
VGXI
Catalent
Miltenyi Biotec GmbH
Sirion-Biotech GmbH
Creative Biogene
Vibalogics
Takara Bio
Cell and Gene Therapy Catapult
Bluebird bio
Addgene
Audentes Therapeutics
BioMarin Pharmaceutical
REGENXBIO
Cobra Biologics Ltd.
Genezen
Advanced BioScience Laboratories, Inc. (ABL, Inc.)
Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
Batavia Biosciences B.V.
Biovion oy
Virovek Incorporation
BioNTech IMFS GmbH
VIVEbiotech S.L.
Aldevron, L.L.C.

Viral Vector Production (Research-use) Market Size

The global market for Viral Vector Production (Research-use) was valued at US$ 1520 million in the year 2024 and is projected to reach a revised size of US$ 4996 million by 2031, growing at a CAGR of 18.8% during the forecast period.

Viral Vector Production (Research-use) Market

Viral Vector Production (Research-use) Market

Viral vectors are increasingly being employed in ongoing clinical trials owing to their efficiency in gene delivery. Significant advancements in delivery vectors that have resulted in the increased therapeutic efficacy of such vectors for gene delivery are driving the market for viral vector production (research-use). Amongst all viral vectors, lentivirus, adeno-associated virus, and adenovirus are the most used vectors across research settings.
North American market for Viral Vector Production (Research-use) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Viral Vector Production (Research-use) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Viral Vector Production (Research-use) in Cell & Gene Therapy Development is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Viral Vector Production (Research-use) include Merck KGaA, Lonza, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Cobra Biologics Ltd., Thermo Fisher Scientific, Waisman Biomanufacturing, Genezen, YPOSKESI, Advanced BioScience Laboratories, Inc. (ABL, Inc.), Novasep Holding S.A.S, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Vector Production (Research-use), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Production (Research-use).
The Viral Vector Production (Research-use) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Vector Production (Research-use) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vector Production (Research-use) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Viral Vector Production (Research-use) Market Report

Report Metric Details
Report Name Viral Vector Production (Research-use) Market
Accounted market size in year US$ 1520 million
Forecasted market size in 2031 US$ 4996 million
CAGR 18.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Adeno-associated virus (AAV)
  • Lentivirus
  • Adenovirus
  • Retrovirus
  • Others
Segment by Application
  • Cell & Gene Therapy Development
  • Vaccine Development
  • Biopharmaceutical and Pharmaceutical Discovery
  • Biomedical Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck KGaA, Lonza, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Cobra Biologics Ltd., Thermo Fisher Scientific, Waisman Biomanufacturing, Genezen, YPOSKESI, Advanced BioScience Laboratories, Inc. (ABL, Inc.), Novasep Holding S.A.S, Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.), Vigene Biosciences, Inc., General Electric Company (GE Healthcare), CEVEC Pharmaceuticals GmbH, Batavia Biosciences B.V., Biovion oy, Wuxi AppTec Co., Ltd., VGXI, Inc., Catalent Inc., Miltenyi Biotec GmbH, SIRION Biotech GmbH, Virovek Incorporation, BioNTech IMFS GmbH, VIVEbiotech S.L., Creative Biogene, Vibalogics GmbH, Takara Bio., Cell and Gene Therapy Catapult, BlueBird Bio, Addgene, Inc., Aldevron, L.L.C., Audentes Therapeutics, BioMarin Pharmaceutical, RegenxBio, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Viral Vector Production (Research-use) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Viral Vector Production (Research-use) Market growing?

Ans: The Viral Vector Production (Research-use) Market witnessing a CAGR of 18.8% during the forecast period 2025-2031.

What is the Viral Vector Production (Research-use) Market size in 2031?

Ans: The Viral Vector Production (Research-use) Market size in 2031 will be US$ 4996 million.

Who are the main players in the Viral Vector Production (Research-use) Market report?

Ans: The main players in the Viral Vector Production (Research-use) Market are Merck KGaA, Lonza, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Cobra Biologics Ltd., Thermo Fisher Scientific, Waisman Biomanufacturing, Genezen, YPOSKESI, Advanced BioScience Laboratories, Inc. (ABL, Inc.), Novasep Holding S.A.S, Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.), Vigene Biosciences, Inc., General Electric Company (GE Healthcare), CEVEC Pharmaceuticals GmbH, Batavia Biosciences B.V., Biovion oy, Wuxi AppTec Co., Ltd., VGXI, Inc., Catalent Inc., Miltenyi Biotec GmbH, SIRION Biotech GmbH, Virovek Incorporation, BioNTech IMFS GmbH, VIVEbiotech S.L., Creative Biogene, Vibalogics GmbH, Takara Bio., Cell and Gene Therapy Catapult, BlueBird Bio, Addgene, Inc., Aldevron, L.L.C., Audentes Therapeutics, BioMarin Pharmaceutical, RegenxBio, Inc.

What are the Application segmentation covered in the Viral Vector Production (Research-use) Market report?

Ans: The Applications covered in the Viral Vector Production (Research-use) Market report are Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical and Pharmaceutical Discovery, Biomedical Research

What are the Type segmentation covered in the Viral Vector Production (Research-use) Market report?

Ans: The Types covered in the Viral Vector Production (Research-use) Market report are Adeno-associated virus (AAV), Lentivirus, Adenovirus, Retrovirus, Others

Recommended Reports

Gene Therapy Markets

Viral Vector Production

Cell & Vaccine Delivery

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Production (Research-use) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adeno-associated virus (AAV)
1.2.3 Lentivirus
1.2.4 Adenovirus
1.2.5 Retrovirus
1.2.6 Others
1.3 Market by Application
1.3.1 Global Viral Vector Production (Research-use) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cell & Gene Therapy Development
1.3.3 Vaccine Development
1.3.4 Biopharmaceutical and Pharmaceutical Discovery
1.3.5 Biomedical Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Production (Research-use) Market Perspective (2020-2031)
2.2 Global Viral Vector Production (Research-use) Growth Trends by Region
2.2.1 Global Viral Vector Production (Research-use) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Viral Vector Production (Research-use) Historic Market Size by Region (2020-2025)
2.2.3 Viral Vector Production (Research-use) Forecasted Market Size by Region (2026-2031)
2.3 Viral Vector Production (Research-use) Market Dynamics
2.3.1 Viral Vector Production (Research-use) Industry Trends
2.3.2 Viral Vector Production (Research-use) Market Drivers
2.3.3 Viral Vector Production (Research-use) Market Challenges
2.3.4 Viral Vector Production (Research-use) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Production (Research-use) Players by Revenue
3.1.1 Global Top Viral Vector Production (Research-use) Players by Revenue (2020-2025)
3.1.2 Global Viral Vector Production (Research-use) Revenue Market Share by Players (2020-2025)
3.2 Global Viral Vector Production (Research-use) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Viral Vector Production (Research-use) Revenue
3.4 Global Viral Vector Production (Research-use) Market Concentration Ratio
3.4.1 Global Viral Vector Production (Research-use) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Production (Research-use) Revenue in 2024
3.5 Global Key Players of Viral Vector Production (Research-use) Head office and Area Served
3.6 Global Key Players of Viral Vector Production (Research-use), Product and Application
3.7 Global Key Players of Viral Vector Production (Research-use), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Production (Research-use) Breakdown Data by Type
4.1 Global Viral Vector Production (Research-use) Historic Market Size by Type (2020-2025)
4.2 Global Viral Vector Production (Research-use) Forecasted Market Size by Type (2026-2031)
5 Viral Vector Production (Research-use) Breakdown Data by Application
5.1 Global Viral Vector Production (Research-use) Historic Market Size by Application (2020-2025)
5.2 Global Viral Vector Production (Research-use) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Viral Vector Production (Research-use) Market Size (2020-2031)
6.2 North America Viral Vector Production (Research-use) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Viral Vector Production (Research-use) Market Size by Country (2020-2025)
6.4 North America Viral Vector Production (Research-use) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector Production (Research-use) Market Size (2020-2031)
7.2 Europe Viral Vector Production (Research-use) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Viral Vector Production (Research-use) Market Size by Country (2020-2025)
7.4 Europe Viral Vector Production (Research-use) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Production (Research-use) Market Size (2020-2031)
8.2 Asia-Pacific Viral Vector Production (Research-use) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Viral Vector Production (Research-use) Market Size by Region (2020-2025)
8.4 Asia-Pacific Viral Vector Production (Research-use) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector Production (Research-use) Market Size (2020-2031)
9.2 Latin America Viral Vector Production (Research-use) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Viral Vector Production (Research-use) Market Size by Country (2020-2025)
9.4 Latin America Viral Vector Production (Research-use) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Production (Research-use) Market Size (2020-2031)
10.2 Middle East & Africa Viral Vector Production (Research-use) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Viral Vector Production (Research-use) Market Size by Country (2020-2025)
10.4 Middle East & Africa Viral Vector Production (Research-use) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Viral Vector Production (Research-use) Introduction
11.1.4 Merck KGaA Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.1.5 Merck KGaA Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Viral Vector Production (Research-use) Introduction
11.2.4 Lonza Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
11.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
11.4 Cobra Biologics Ltd.
11.4.1 Cobra Biologics Ltd. Company Details
11.4.2 Cobra Biologics Ltd. Business Overview
11.4.3 Cobra Biologics Ltd. Viral Vector Production (Research-use) Introduction
11.4.4 Cobra Biologics Ltd. Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.4.5 Cobra Biologics Ltd. Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Viral Vector Production (Research-use) Introduction
11.5.4 Thermo Fisher Scientific Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Waisman Biomanufacturing
11.6.1 Waisman Biomanufacturing Company Details
11.6.2 Waisman Biomanufacturing Business Overview
11.6.3 Waisman Biomanufacturing Viral Vector Production (Research-use) Introduction
11.6.4 Waisman Biomanufacturing Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.6.5 Waisman Biomanufacturing Recent Development
11.7 Genezen
11.7.1 Genezen Company Details
11.7.2 Genezen Business Overview
11.7.3 Genezen Viral Vector Production (Research-use) Introduction
11.7.4 Genezen Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.7.5 Genezen Recent Development
11.8 YPOSKESI
11.8.1 YPOSKESI Company Details
11.8.2 YPOSKESI Business Overview
11.8.3 YPOSKESI Viral Vector Production (Research-use) Introduction
11.8.4 YPOSKESI Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.8.5 YPOSKESI Recent Development
11.9 Advanced BioScience Laboratories, Inc. (ABL, Inc.)
11.9.1 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Company Details
11.9.2 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Business Overview
11.9.3 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Introduction
11.9.4 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.9.5 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Recent Development
11.10 Novasep Holding S.A.S
11.10.1 Novasep Holding S.A.S Company Details
11.10.2 Novasep Holding S.A.S Business Overview
11.10.3 Novasep Holding S.A.S Viral Vector Production (Research-use) Introduction
11.10.4 Novasep Holding S.A.S Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.10.5 Novasep Holding S.A.S Recent Development
11.11 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
11.11.1 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Company Details
11.11.2 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Business Overview
11.11.3 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Introduction
11.11.4 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.11.5 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Recent Development
11.12 Vigene Biosciences, Inc.
11.12.1 Vigene Biosciences, Inc. Company Details
11.12.2 Vigene Biosciences, Inc. Business Overview
11.12.3 Vigene Biosciences, Inc. Viral Vector Production (Research-use) Introduction
11.12.4 Vigene Biosciences, Inc. Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.12.5 Vigene Biosciences, Inc. Recent Development
11.13 General Electric Company (GE Healthcare)
11.13.1 General Electric Company (GE Healthcare) Company Details
11.13.2 General Electric Company (GE Healthcare) Business Overview
11.13.3 General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Introduction
11.13.4 General Electric Company (GE Healthcare) Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.13.5 General Electric Company (GE Healthcare) Recent Development
11.14 CEVEC Pharmaceuticals GmbH
11.14.1 CEVEC Pharmaceuticals GmbH Company Details
11.14.2 CEVEC Pharmaceuticals GmbH Business Overview
11.14.3 CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Introduction
11.14.4 CEVEC Pharmaceuticals GmbH Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.14.5 CEVEC Pharmaceuticals GmbH Recent Development
11.15 Batavia Biosciences B.V.
11.15.1 Batavia Biosciences B.V. Company Details
11.15.2 Batavia Biosciences B.V. Business Overview
11.15.3 Batavia Biosciences B.V. Viral Vector Production (Research-use) Introduction
11.15.4 Batavia Biosciences B.V. Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.15.5 Batavia Biosciences B.V. Recent Development
11.16 Biovion oy
11.16.1 Biovion oy Company Details
11.16.2 Biovion oy Business Overview
11.16.3 Biovion oy Viral Vector Production (Research-use) Introduction
11.16.4 Biovion oy Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.16.5 Biovion oy Recent Development
11.17 Wuxi AppTec Co., Ltd.
11.17.1 Wuxi AppTec Co., Ltd. Company Details
11.17.2 Wuxi AppTec Co., Ltd. Business Overview
11.17.3 Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Introduction
11.17.4 Wuxi AppTec Co., Ltd. Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.17.5 Wuxi AppTec Co., Ltd. Recent Development
11.18 VGXI, Inc.
11.18.1 VGXI, Inc. Company Details
11.18.2 VGXI, Inc. Business Overview
11.18.3 VGXI, Inc. Viral Vector Production (Research-use) Introduction
11.18.4 VGXI, Inc. Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.18.5 VGXI, Inc. Recent Development
11.19 Catalent Inc.
11.19.1 Catalent Inc. Company Details
11.19.2 Catalent Inc. Business Overview
11.19.3 Catalent Inc. Viral Vector Production (Research-use) Introduction
11.19.4 Catalent Inc. Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.19.5 Catalent Inc. Recent Development
11.20 Miltenyi Biotec GmbH
11.20.1 Miltenyi Biotec GmbH Company Details
11.20.2 Miltenyi Biotec GmbH Business Overview
11.20.3 Miltenyi Biotec GmbH Viral Vector Production (Research-use) Introduction
11.20.4 Miltenyi Biotec GmbH Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.20.5 Miltenyi Biotec GmbH Recent Development
11.21 SIRION Biotech GmbH
11.21.1 SIRION Biotech GmbH Company Details
11.21.2 SIRION Biotech GmbH Business Overview
11.21.3 SIRION Biotech GmbH Viral Vector Production (Research-use) Introduction
11.21.4 SIRION Biotech GmbH Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.21.5 SIRION Biotech GmbH Recent Development
11.22 Virovek Incorporation
11.22.1 Virovek Incorporation Company Details
11.22.2 Virovek Incorporation Business Overview
11.22.3 Virovek Incorporation Viral Vector Production (Research-use) Introduction
11.22.4 Virovek Incorporation Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.22.5 Virovek Incorporation Recent Development
11.23 BioNTech IMFS GmbH
11.23.1 BioNTech IMFS GmbH Company Details
11.23.2 BioNTech IMFS GmbH Business Overview
11.23.3 BioNTech IMFS GmbH Viral Vector Production (Research-use) Introduction
11.23.4 BioNTech IMFS GmbH Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.23.5 BioNTech IMFS GmbH Recent Development
11.24 VIVEbiotech S.L.
11.24.1 VIVEbiotech S.L. Company Details
11.24.2 VIVEbiotech S.L. Business Overview
11.24.3 VIVEbiotech S.L. Viral Vector Production (Research-use) Introduction
11.24.4 VIVEbiotech S.L. Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.24.5 VIVEbiotech S.L. Recent Development
11.25 Creative Biogene
11.25.1 Creative Biogene Company Details
11.25.2 Creative Biogene Business Overview
11.25.3 Creative Biogene Viral Vector Production (Research-use) Introduction
11.25.4 Creative Biogene Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.25.5 Creative Biogene Recent Development
11.26 Vibalogics GmbH
11.26.1 Vibalogics GmbH Company Details
11.26.2 Vibalogics GmbH Business Overview
11.26.3 Vibalogics GmbH Viral Vector Production (Research-use) Introduction
11.26.4 Vibalogics GmbH Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.26.5 Vibalogics GmbH Recent Development
11.27 Takara Bio.
11.27.1 Takara Bio. Company Details
11.27.2 Takara Bio. Business Overview
11.27.3 Takara Bio. Viral Vector Production (Research-use) Introduction
11.27.4 Takara Bio. Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.27.5 Takara Bio. Recent Development
11.28 Cell and Gene Therapy Catapult
11.28.1 Cell and Gene Therapy Catapult Company Details
11.28.2 Cell and Gene Therapy Catapult Business Overview
11.28.3 Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Introduction
11.28.4 Cell and Gene Therapy Catapult Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.28.5 Cell and Gene Therapy Catapult Recent Development
11.29 BlueBird Bio
11.29.1 BlueBird Bio Company Details
11.29.2 BlueBird Bio Business Overview
11.29.3 BlueBird Bio Viral Vector Production (Research-use) Introduction
11.29.4 BlueBird Bio Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.29.5 BlueBird Bio Recent Development
11.30 Addgene, Inc.
11.30.1 Addgene, Inc. Company Details
11.30.2 Addgene, Inc. Business Overview
11.30.3 Addgene, Inc. Viral Vector Production (Research-use) Introduction
11.30.4 Addgene, Inc. Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.30.5 Addgene, Inc. Recent Development
11.31 Aldevron, L.L.C.
11.31.1 Aldevron, L.L.C. Company Details
11.31.2 Aldevron, L.L.C. Business Overview
11.31.3 Aldevron, L.L.C. Viral Vector Production (Research-use) Introduction
11.31.4 Aldevron, L.L.C. Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.31.5 Aldevron, L.L.C. Recent Development
11.32 Audentes Therapeutics
11.32.1 Audentes Therapeutics Company Details
11.32.2 Audentes Therapeutics Business Overview
11.32.3 Audentes Therapeutics Viral Vector Production (Research-use) Introduction
11.32.4 Audentes Therapeutics Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.32.5 Audentes Therapeutics Recent Development
11.33 BioMarin Pharmaceutical
11.33.1 BioMarin Pharmaceutical Company Details
11.33.2 BioMarin Pharmaceutical Business Overview
11.33.3 BioMarin Pharmaceutical Viral Vector Production (Research-use) Introduction
11.33.4 BioMarin Pharmaceutical Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.33.5 BioMarin Pharmaceutical Recent Development
11.34 RegenxBio, Inc.
11.34.1 RegenxBio, Inc. Company Details
11.34.2 RegenxBio, Inc. Business Overview
11.34.3 RegenxBio, Inc. Viral Vector Production (Research-use) Introduction
11.34.4 RegenxBio, Inc. Revenue in Viral Vector Production (Research-use) Business (2020-2025)
11.34.5 RegenxBio, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Merck KGaA
Lonza
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Thermo Fisher Scientific
Waisman Biomanufacturing
Yposkesi
Novasep Holding S.A.S.
Vigene Biosciences, Inc.
GENERAL ELECTRIC COMPANY (GE Healthcare)
Cevec Pharmaceuticals GmbH
Wuxi Apptec Co.,Ltd.
VGXI
Catalent
Miltenyi Biotec GmbH
Sirion-Biotech GmbH
Creative Biogene
Vibalogics
Takara Bio
Cell and Gene Therapy Catapult
Bluebird bio
Addgene
Audentes Therapeutics
BioMarin Pharmaceutical
REGENXBIO
Cobra Biologics Ltd.
Genezen
Advanced BioScience Laboratories, Inc. (ABL, Inc.)
Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
Batavia Biosciences B.V.
Biovion oy
Virovek Incorporation
BioNTech IMFS GmbH
VIVEbiotech S.L.
Aldevron, L.L.C.
List of Tables
 Table 1. Global Viral Vector Production (Research-use) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Adeno-associated virus (AAV)
 Table 3. Key Players of Lentivirus
 Table 4. Key Players of Adenovirus
 Table 5. Key Players of Retrovirus
 Table 6. Key Players of Others
 Table 7. Global Viral Vector Production (Research-use) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Viral Vector Production (Research-use) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Viral Vector Production (Research-use) Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Viral Vector Production (Research-use) Market Share by Region (2020-2025)
 Table 11. Global Viral Vector Production (Research-use) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Viral Vector Production (Research-use) Market Share by Region (2026-2031)
 Table 13. Viral Vector Production (Research-use) Market Trends
 Table 14. Viral Vector Production (Research-use) Market Drivers
 Table 15. Viral Vector Production (Research-use) Market Challenges
 Table 16. Viral Vector Production (Research-use) Market Restraints
 Table 17. Global Viral Vector Production (Research-use) Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Viral Vector Production (Research-use) Market Share by Players (2020-2025)
 Table 19. Global Top Viral Vector Production (Research-use) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Production (Research-use) as of 2024)
 Table 20. Ranking of Global Top Viral Vector Production (Research-use) Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Viral Vector Production (Research-use) Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Viral Vector Production (Research-use), Headquarters and Area Served
 Table 23. Global Key Players of Viral Vector Production (Research-use), Product and Application
 Table 24. Global Key Players of Viral Vector Production (Research-use), Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Viral Vector Production (Research-use) Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Viral Vector Production (Research-use) Revenue Market Share by Type (2020-2025)
 Table 28. Global Viral Vector Production (Research-use) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Viral Vector Production (Research-use) Revenue Market Share by Type (2026-2031)
 Table 30. Global Viral Vector Production (Research-use) Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Viral Vector Production (Research-use) Revenue Market Share by Application (2020-2025)
 Table 32. Global Viral Vector Production (Research-use) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Viral Vector Production (Research-use) Revenue Market Share by Application (2026-2031)
 Table 34. North America Viral Vector Production (Research-use) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Viral Vector Production (Research-use) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Viral Vector Production (Research-use) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Viral Vector Production (Research-use) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Viral Vector Production (Research-use) Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Viral Vector Production (Research-use) Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Viral Vector Production (Research-use) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Viral Vector Production (Research-use) Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Viral Vector Production (Research-use) Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Viral Vector Production (Research-use) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Viral Vector Production (Research-use) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Viral Vector Production (Research-use) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Viral Vector Production (Research-use) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Viral Vector Production (Research-use) Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Viral Vector Production (Research-use) Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Merck KGaA Company Details
 Table 50. Merck KGaA Business Overview
 Table 51. Merck KGaA Viral Vector Production (Research-use) Product
 Table 52. Merck KGaA Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 53. Merck KGaA Recent Development
 Table 54. Lonza Company Details
 Table 55. Lonza Business Overview
 Table 56. Lonza Viral Vector Production (Research-use) Product
 Table 57. Lonza Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 58. Lonza Recent Development
 Table 59. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
 Table 60. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
 Table 61. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Product
 Table 62. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 63. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
 Table 64. Cobra Biologics Ltd. Company Details
 Table 65. Cobra Biologics Ltd. Business Overview
 Table 66. Cobra Biologics Ltd. Viral Vector Production (Research-use) Product
 Table 67. Cobra Biologics Ltd. Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 68. Cobra Biologics Ltd. Recent Development
 Table 69. Thermo Fisher Scientific Company Details
 Table 70. Thermo Fisher Scientific Business Overview
 Table 71. Thermo Fisher Scientific Viral Vector Production (Research-use) Product
 Table 72. Thermo Fisher Scientific Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 73. Thermo Fisher Scientific Recent Development
 Table 74. Waisman Biomanufacturing Company Details
 Table 75. Waisman Biomanufacturing Business Overview
 Table 76. Waisman Biomanufacturing Viral Vector Production (Research-use) Product
 Table 77. Waisman Biomanufacturing Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 78. Waisman Biomanufacturing Recent Development
 Table 79. Genezen Company Details
 Table 80. Genezen Business Overview
 Table 81. Genezen Viral Vector Production (Research-use) Product
 Table 82. Genezen Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 83. Genezen Recent Development
 Table 84. YPOSKESI Company Details
 Table 85. YPOSKESI Business Overview
 Table 86. YPOSKESI Viral Vector Production (Research-use) Product
 Table 87. YPOSKESI Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 88. YPOSKESI Recent Development
 Table 89. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Company Details
 Table 90. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Business Overview
 Table 91. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Product
 Table 92. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 93. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Recent Development
 Table 94. Novasep Holding S.A.S Company Details
 Table 95. Novasep Holding S.A.S Business Overview
 Table 96. Novasep Holding S.A.S Viral Vector Production (Research-use) Product
 Table 97. Novasep Holding S.A.S Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 98. Novasep Holding S.A.S Recent Development
 Table 99. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Company Details
 Table 100. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Business Overview
 Table 101. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Product
 Table 102. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 103. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Recent Development
 Table 104. Vigene Biosciences, Inc. Company Details
 Table 105. Vigene Biosciences, Inc. Business Overview
 Table 106. Vigene Biosciences, Inc. Viral Vector Production (Research-use) Product
 Table 107. Vigene Biosciences, Inc. Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 108. Vigene Biosciences, Inc. Recent Development
 Table 109. General Electric Company (GE Healthcare) Company Details
 Table 110. General Electric Company (GE Healthcare) Business Overview
 Table 111. General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Product
 Table 112. General Electric Company (GE Healthcare) Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 113. General Electric Company (GE Healthcare) Recent Development
 Table 114. CEVEC Pharmaceuticals GmbH Company Details
 Table 115. CEVEC Pharmaceuticals GmbH Business Overview
 Table 116. CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Product
 Table 117. CEVEC Pharmaceuticals GmbH Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 118. CEVEC Pharmaceuticals GmbH Recent Development
 Table 119. Batavia Biosciences B.V. Company Details
 Table 120. Batavia Biosciences B.V. Business Overview
 Table 121. Batavia Biosciences B.V. Viral Vector Production (Research-use) Product
 Table 122. Batavia Biosciences B.V. Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 123. Batavia Biosciences B.V. Recent Development
 Table 124. Biovion oy Company Details
 Table 125. Biovion oy Business Overview
 Table 126. Biovion oy Viral Vector Production (Research-use) Product
 Table 127. Biovion oy Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 128. Biovion oy Recent Development
 Table 129. Wuxi AppTec Co., Ltd. Company Details
 Table 130. Wuxi AppTec Co., Ltd. Business Overview
 Table 131. Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Product
 Table 132. Wuxi AppTec Co., Ltd. Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 133. Wuxi AppTec Co., Ltd. Recent Development
 Table 134. VGXI, Inc. Company Details
 Table 135. VGXI, Inc. Business Overview
 Table 136. VGXI, Inc. Viral Vector Production (Research-use) Product
 Table 137. VGXI, Inc. Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 138. VGXI, Inc. Recent Development
 Table 139. Catalent Inc. Company Details
 Table 140. Catalent Inc. Business Overview
 Table 141. Catalent Inc. Viral Vector Production (Research-use) Product
 Table 142. Catalent Inc. Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 143. Catalent Inc. Recent Development
 Table 144. Miltenyi Biotec GmbH Company Details
 Table 145. Miltenyi Biotec GmbH Business Overview
 Table 146. Miltenyi Biotec GmbH Viral Vector Production (Research-use) Product
 Table 147. Miltenyi Biotec GmbH Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 148. Miltenyi Biotec GmbH Recent Development
 Table 149. SIRION Biotech GmbH Company Details
 Table 150. SIRION Biotech GmbH Business Overview
 Table 151. SIRION Biotech GmbH Viral Vector Production (Research-use) Product
 Table 152. SIRION Biotech GmbH Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 153. SIRION Biotech GmbH Recent Development
 Table 154. Virovek Incorporation Company Details
 Table 155. Virovek Incorporation Business Overview
 Table 156. Virovek Incorporation Viral Vector Production (Research-use) Product
 Table 157. Virovek Incorporation Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 158. Virovek Incorporation Recent Development
 Table 159. BioNTech IMFS GmbH Company Details
 Table 160. BioNTech IMFS GmbH Business Overview
 Table 161. BioNTech IMFS GmbH Viral Vector Production (Research-use) Product
 Table 162. BioNTech IMFS GmbH Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 163. BioNTech IMFS GmbH Recent Development
 Table 164. VIVEbiotech S.L. Company Details
 Table 165. VIVEbiotech S.L. Business Overview
 Table 166. VIVEbiotech S.L. Viral Vector Production (Research-use) Product
 Table 167. VIVEbiotech S.L. Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 168. VIVEbiotech S.L. Recent Development
 Table 169. Creative Biogene Company Details
 Table 170. Creative Biogene Business Overview
 Table 171. Creative Biogene Viral Vector Production (Research-use) Product
 Table 172. Creative Biogene Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 173. Creative Biogene Recent Development
 Table 174. Vibalogics GmbH Company Details
 Table 175. Vibalogics GmbH Business Overview
 Table 176. Vibalogics GmbH Viral Vector Production (Research-use) Product
 Table 177. Vibalogics GmbH Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 178. Vibalogics GmbH Recent Development
 Table 179. Takara Bio. Company Details
 Table 180. Takara Bio. Business Overview
 Table 181. Takara Bio. Viral Vector Production (Research-use) Product
 Table 182. Takara Bio. Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 183. Takara Bio. Recent Development
 Table 184. Cell and Gene Therapy Catapult Company Details
 Table 185. Cell and Gene Therapy Catapult Business Overview
 Table 186. Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Product
 Table 187. Cell and Gene Therapy Catapult Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 188. Cell and Gene Therapy Catapult Recent Development
 Table 189. BlueBird Bio Company Details
 Table 190. BlueBird Bio Business Overview
 Table 191. BlueBird Bio Viral Vector Production (Research-use) Product
 Table 192. BlueBird Bio Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 193. BlueBird Bio Recent Development
 Table 194. Addgene, Inc. Company Details
 Table 195. Addgene, Inc. Business Overview
 Table 196. Addgene, Inc. Viral Vector Production (Research-use) Product
 Table 197. Addgene, Inc. Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 198. Addgene, Inc. Recent Development
 Table 199. Aldevron, L.L.C. Company Details
 Table 200. Aldevron, L.L.C. Business Overview
 Table 201. Aldevron, L.L.C. Viral Vector Production (Research-use) Product
 Table 202. Aldevron, L.L.C. Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 203. Aldevron, L.L.C. Recent Development
 Table 204. Audentes Therapeutics Company Details
 Table 205. Audentes Therapeutics Business Overview
 Table 206. Audentes Therapeutics Viral Vector Production (Research-use) Product
 Table 207. Audentes Therapeutics Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 208. Audentes Therapeutics Recent Development
 Table 209. BioMarin Pharmaceutical Company Details
 Table 210. BioMarin Pharmaceutical Business Overview
 Table 211. BioMarin Pharmaceutical Viral Vector Production (Research-use) Product
 Table 212. BioMarin Pharmaceutical Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 213. BioMarin Pharmaceutical Recent Development
 Table 214. RegenxBio, Inc. Company Details
 Table 215. RegenxBio, Inc. Business Overview
 Table 216. RegenxBio, Inc. Viral Vector Production (Research-use) Product
 Table 217. RegenxBio, Inc. Revenue in Viral Vector Production (Research-use) Business (2020-2025) & (US$ Million)
 Table 218. RegenxBio, Inc. Recent Development
 Table 219. Research Programs/Design for This Report
 Table 220. Key Data Information from Secondary Sources
 Table 221. Key Data Information from Primary Sources
 Table 222. Authors List of This Report


List of Figures
 Figure 1. Viral Vector Production (Research-use) Picture
 Figure 2. Global Viral Vector Production (Research-use) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Viral Vector Production (Research-use) Market Share by Type: 2024 VS 2031
 Figure 4. Adeno-associated virus (AAV) Features
 Figure 5. Lentivirus Features
 Figure 6. Adenovirus Features
 Figure 7. Retrovirus Features
 Figure 8. Others Features
 Figure 9. Global Viral Vector Production (Research-use) Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Viral Vector Production (Research-use) Market Share by Application: 2024 VS 2031
 Figure 11. Cell & Gene Therapy Development Case Studies
 Figure 12. Vaccine Development Case Studies
 Figure 13. Biopharmaceutical and Pharmaceutical Discovery Case Studies
 Figure 14. Biomedical Research Case Studies
 Figure 15. Viral Vector Production (Research-use) Report Years Considered
 Figure 16. Global Viral Vector Production (Research-use) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Viral Vector Production (Research-use) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Viral Vector Production (Research-use) Market Share by Region: 2024 VS 2031
 Figure 19. Global Viral Vector Production (Research-use) Market Share by Players in 2024
 Figure 20. Global Top Viral Vector Production (Research-use) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Production (Research-use) as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Viral Vector Production (Research-use) Revenue in 2024
 Figure 22. North America Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Viral Vector Production (Research-use) Market Share by Country (2020-2031)
 Figure 24. United States Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Viral Vector Production (Research-use) Market Share by Country (2020-2031)
 Figure 28. Germany Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Viral Vector Production (Research-use) Market Share by Region (2020-2031)
 Figure 36. China Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Viral Vector Production (Research-use) Market Share by Country (2020-2031)
 Figure 44. Mexico Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Viral Vector Production (Research-use) Market Share by Country (2020-2031)
 Figure 48. Turkey Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Viral Vector Production (Research-use) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Merck KGaA Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 52. Lonza Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 53. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 54. Cobra Biologics Ltd. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 56. Waisman Biomanufacturing Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 57. Genezen Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 58. YPOSKESI Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 59. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 60. Novasep Holding S.A.S Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 61. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 62. Vigene Biosciences, Inc. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 63. General Electric Company (GE Healthcare) Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 64. CEVEC Pharmaceuticals GmbH Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 65. Batavia Biosciences B.V. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 66. Biovion oy Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 67. Wuxi AppTec Co., Ltd. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 68. VGXI, Inc. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 69. Catalent Inc. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 70. Miltenyi Biotec GmbH Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 71. SIRION Biotech GmbH Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 72. Virovek Incorporation Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 73. BioNTech IMFS GmbH Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 74. VIVEbiotech S.L. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 75. Creative Biogene Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 76. Vibalogics GmbH Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 77. Takara Bio. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 78. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 79. BlueBird Bio Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 80. Addgene, Inc. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 81. Aldevron, L.L.C. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 82. Audentes Therapeutics Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 83. BioMarin Pharmaceutical Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 84. RegenxBio, Inc. Revenue Growth Rate in Viral Vector Production (Research-use) Business (2020-2025)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Viral Vector Manufacturing Market Research Report 2024
Global Viral Vectors Gene Therapy Market Research Report 2025
Viral Vector and Plasmid DNA Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Vector Manufacturing for Gene Therapy Market Research Report 2024
Global Adeno Associated Virus Production Market Research Report 2024
Global Viral and Non viral Vector Market Research Report 2024
Adeno Associated Virus AAV Vector Based Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy Viral Vector and Plasmid DNA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AAV Vector Gene Therapy Market Research Report 2024
Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2025
Viral Vector and Plasmid DNA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Vector Based Gene Therapy Drugs Market Research Report 2024
Global GMP Viral Vector Manufacturing Market Research Report 2024
Global Viral Vectors Non Viral Vectors and Gene Therapy Manufacturing Market Research Report 2024
Global Viral Vector Based Gene Therapy Market Research Report 2025
Lentivirus Particle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Vector Development and Manufacturing Services Market Research Report 2025
Global Research Grade Viral Vector Packaging Service Market Research Report 2025
Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions